EXAS

NASDAQ · Biotechnology

Exact Sciences Corp

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$104.91

+0.99 (+0.95%)

As of Aug 1, 1:10 AM ET ·

Analyst Consensus

Hold

Analysts

High

Coverage

Buy 8 28%

Hold 21 72%

Sell 0 0%

Price Target

Analyst Price Target +24.6% upside

Low Target $80.73

Average Target $130.71

High Target $205.54

Current Price $104.91

Current
$104.91

Target
$130.71

$80.73 $130.71 avg $205.54

Scenario Analysis

Bear Case

$80.73

-23.0%

Low target

Base Case

$130.71

+24.6%

Avg target

Bull Case

$205.54

+95.9%

High target

Risk/Reward

4.2x

Highly favorable

Price in Context

52-Week High

$104.98

-0.1% from high

52-Week Low

$38.81

+170.3% from low

50-Day SMA

$102.19

+2.7% vs SMA

200-Day SMA

$69.24

+51.5% vs SMA

RSI (14)

74.6

Overbought

Target vs 52W High

$130.71

+24.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%